• 1
    Sherrard DJ, Andress DL 1988 Renal osteodystrophy. In: SchrierRW, GottschalkCW (eds.) Diseases of the Kidney. Little, Brown and Co., Boston, MA, U.S.A., pp. 30353062.
  • 2
    Brickman AS, Coburn JW, Massry SG, Normal AW 1974 1,25 dihydroxyvitamin D3 in normal man and patients with renal failure Ann Intern Med 80:161163.
  • 3
    Hauschka PV, Lian JB, Cole DEC, Gundberg CM 1989 Osteocalcin and matrix Gla protein: Vitamin K-dependent proteins in bone Physiol Rev 69:9901047.
  • 4
    Termine JD 1990 Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 1st Ed. FavusMJ (ed.) Raven Press, New York, NY, U.S.A., pp. 1618.
  • 5
    Glowacki J, Lian JB 1987 Impaired recruitment and differentiation of osteoclast progenitors by osteocalcin-deplete bone implants Cell Differ 21:247254.
  • 6
    Charhon SA, Delmas PD, Malaval L, Chavassieux PM, Arlot M, Chapuy MC, Meunier PJ 1986 Serum bone Gla-protein in renal osteodystrophy: Comparison with bone histomorphometry J Clin Endocrinol Metab 63:892897.
  • 7
    Nakatsuka K, Midi T, Nishiuawa Y, Tabata T, Inoue T, Morii H, Ogata E 1991 In: Calcium-regulating hormone. I. Role in disease and Ageing, Vol 90. In: MoriiH (ed.) Contributions to Nephrology. Karger, Basel, Switzerland, pp. 147154.
  • 8
    Andress DL 1993 Blood aluminum in renal osteodystrophy. In: FavusMJ (ed.) Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 2nd ed. Raven Press, New York, NY, U.S.A., pp. 112114.
  • 9
    Milliner DS, Nebeker HS, Ott SM, Andress DL, Sherrard DJ, Alfrey AL, Slatopolsky EA, Coburn JW 1984 Use of the deferoxamine infusion test in the diagnosis of aluminum-related osteodystrophy Ann Intern Med 101:775780.
  • 10
    Hodsman AB, Hood SA, Brown P, Cordy PE 1985 Do serum aluminum levels reflect underlying skeletal aluminum accumulation and bone histology before or after chelation by deferoxamine? J Lab Clin Med 106:674681.
  • 11
    Llach F, Felsenfeld AJ, Coleman MD, Keveney JJ, Perderson JA, Medlock TR 1986 The natural course of dialysis osteomalacia Kidney Int 29 (Suppl 18):7479.
  • 12
    Schmidt H, Stracke H, Schatz H, Scheuermann EH, Fassbinder W, Schowppe W 1989 Osteocalcin serum levels in patients following renal transplantation Klin Wochenschr 67:297303.
  • 13
    Miller JL, Hubbard CM, Litman BJ, Macdonald TL 1989 Inhibition of transducin activation and guanosine triphosphatase activity by aluminum ion J Biol Chem 264:243250.
  • 14
    Northup JK, Smigel MD, Sternweiss PC, Gilman AG 1983 The subunits of the stimulatory regulatory component of adenylate cyclase: Resolution of the activated 45,000-dalton (alpha) subunit J Biol Chem 258:1136911376.
  • 15
    Mansour JM, Ehrlich A, Mansour TC 1983 Dual effects of aluminum as activator and inhibitor of adenylate cyclase in the liver fluke Fasciola hepatica. Biochem Biophys Res Commun 112:911918.
  • 16
    Galceran T, Finch J, Bergfeld M, Coburn J, Teitelbaum S, Martin K, Slatopolsky E 1985 Biological effects of aluminum on the isolated perfused bone Kidney Int 27:116.
  • 17
    Lieberherr M, Grosse B, Cournot-Witmer G, Hermann-Erlee MPM, Balsan S 1987 Aluminum action on mouse bone cell metabolism and response to PTH and 1,25(OH)2D3 Kidney Int 31:736743.
  • 18
    Pun KK, Ho PWM, Lau P 1990 Effects of aluminum on the parathyroid hormone receptors of bone and kidney Kidney Int 37:7278.
  • 19
    Lajeunesse D, Frondoza C, Schoffield B, Sacktor B 1990 Osteocalcin secretion by the human osteosarcoma cell line MG-63 J Bone Miner Res 5:915922.
  • 20
    Lajeunesse D, Kiebzak GM, Frondoza C, Sacktor B 1991 Regulation of osteocalcin secretion by human primary bone cells and by the human osteosarcoma cell line MG-63 Bone Miner 14:237250.
  • 21
    Lajeunesse D 1994 Effect of 17 β-estradiol on the human osteosarcoma cell line MG-63 Bone Miner 24:116.
  • 22
    Peterkofsky B, Diegelman R 1971 Use of a mixture of proteinase-free collagenase for the specific assay of radioactive collagen in the presence of other proteins Biochemistry 10:988994.
  • 23
    Ecarot-Charrier B, Glorieux FH 1983 Effects of phosphate and 1,25(OH)2D3 on in vitro bone collagen synthesis in the hypophosphatemic mouse Calcif Tissue Int 35:383391.
  • 24
    Chomczynski P, Sacchi N 1987 Single step method RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction Anal Biochem 162:156159.
  • 25
    Goodman WG, Henry DA, Horst R, Nudelman RK, Alfrey AC, Coburn JW 1984 Parenteral aluminum administration in the dog. II. Induction of osteomalacia and effect on vitamin D metabolism Kidney Int 25:370375.
  • 26
    Coen G, Mazzaferro S, Costantini S, Ballanti P, Carrieri MP, Giordano R, Smacchi A, Sardella D, Bonnuci E, Taggi F 1989 Bone aluminum content in predialysis chronic renal failure and its relation with secondary hyperparathyroidism and 1,25(OH)2D3 treatment Miner Electrolyte Metab 15:295302.
  • 27
    Coburn JW, Norris KC 1986 Diagnosis of aluminum-related bone disease and treatment of aluminum toxicity with deferoxamine Semin Nephrol 6 (Suppl 1):1221.
  • 28
    Salusky IB, Coburn JW, Brill J, Foley J, Slatopolsky E, Fine RN, Goodman WG 1988 Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD Kidney Int 33:975982.
  • 29
    Lieberherr M, Grosse B, Cournot-Witmer G, Thil CL, Balsan S 1982 In vitro effects of aluminum on bone phosphatases: A possible interaction with bPTH and vitamin D3 metabolites Calcif Tissue Int 34:280284.
  • 30
    Ikeda K, Matsumoto T, Morita K, Kurokawa K, Ogata E 1986 Inhibition of in vitro mineralization by aluminum in a clonal osteoblastlike cell line, MC3T3-E1 Calcif Tissue Int 39:319323.
  • 31
    Kasai K, Hori MT, Goodman WG 1991 Transferrin enhances the anti-proliferative actions of aluminum in osteoblast-like cells Am J Physiol 260:E537E543.
  • 32
    Rodriguez M, Felsenfeld AJ, Lach F 1990 Aluminum administration in the rat separately affects the osteoblast and bone mineralization J Bone Miner Res 5:5967.
  • 33
    Chan JCW, Jacob M, Brown S, Savory J, Wills MR 1988 Aluminum metabolism in rats: Effects of vitamin D, dihydrotachysterol, 1,25-dihydroxyvitamin D and phosphate binders Nephron 48:6164.
  • 34
    Vukicevic S, Krempien B, Stavljenic A 1987 Effects of 1α,25- and 24R,25-dihydroxyvitamin D3 on aluminum-induced rickets in growing rats J Bone Miner Res 2:533545.
  • 35
    Marie PJ, Lomri A, de Vernejoul MC, Morieux C, Graulet A-M, Guéris J, Llach F 1989 Relationships between histomorphometric features of bone formation and bone cell characteristics in vitro in renal osteodystrophy J Clin Endocrinol Metab 69:11661173.
  • 36
    Laurenza A, McHugh Sutkowski E, Seamon KB 1989 Forskolin: A specific stimulator of adenylyl cyclase or a diterpene with multiple sites of action? Trends Pharm Sci 10:442447.
  • 37
    Abou-Samra A-B, Jueppner H, Potts JT, Segre GV 1989 Inactivation of pertussis toxin-sensitive guanyl nucleotide-binding proteins increase parathyroid hormone receptors and reverse agonist-induced receptor down-regulation in ROS 17/2.8 cells Endocrinology 125:25942599.
  • 38
    Freissmuth M, Casey PJ, Gilman AG 1989 G proteins control diverse pathways of transmembrane signaling FASEB J 3:21252131.